Huse K, Röhner G
Anasth Intensivther Notfallmed. 1980 Apr;15(2):152-8.
In 32 neurosurgical patients in neuroleptanaesthesia and controlled hypotension the following hemodynamic parameters were studied. Blood pressure, heart rate, cardiac output in addition serial measurements of the blood gasanalysis, oxygen content were performed from the arterial and centralvenous blood samples. In the first collective of 12 patients a mean dosis of 45 +/- 12 mg dihydrazinophthalazine (Nepresol) decreased the blood pressure to a mean value of 55 +/- 7 mm Hg. In spite of this blood pressure drop the cardiac output increased by 62,4% in consequence to the increase of the heart rate by 27% and the stroke volume by 19,9%. A controlled hypotension to a mean value of 57 +/- 9 mm Hg was performed in 20 patients with sodiumnitroprusside. In contrast to the effects of Nepresol after medication of sodiumnitroprusside the cardiac output decreased by 16% the stroke index by 24% while the heart rate increased by 18%. Both drugs have a useful place in neuroanesthesia, but sodiumnitroprusside is the drug of choice for controlled hypotension, because after medication of Nepresol even in the higher dose range there is no dose-response-relationship and the onset of action is delayed.
在32例接受神经安定麻醉和控制性低血压的神经外科患者中,研究了以下血流动力学参数。测量了血压、心率、心输出量,此外还对动脉血和中心静脉血样本进行了血气分析、氧含量的系列测定。在第一组12例患者中,平均剂量为45±12mg双肼屈嗪(血压达静)使血压降至平均值55±7mmHg。尽管血压下降,但由于心率增加27%和每搏量增加19.9%,心输出量增加了62.4%。20例患者使用硝普钠进行控制性低血压,使平均血压降至57±9mmHg。与使用双肼屈嗪后的效果相反,使用硝普钠后心输出量下降了16%,每搏指数下降了24%,而心率增加了18%。两种药物在神经麻醉中都有一定作用,但硝普钠是控制性低血压的首选药物,因为即使在较高剂量范围内使用双肼屈嗪,也不存在剂量反应关系,且起效延迟。